COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes

By afschroeder • July 18, 2025

Hahn EE, Eng S, Chen A, Haupt EC, Goodall S, Munoz-Plaza CE, Nguyen HQ, Gould MK, Ganz PA, Shen E. COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes. JAMA Oncol. 2025 Jul 17. doi: 10.1001/jamaoncol.2025.1991. Epub ahead of print. PMID: 40674101.

Tags: Hematology/Oncology, Publications

Related Posts

Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer

Choueiri TK, Merchán J, Patnaik A, Drakaki A, Rini BI, Rha SY, Lee JL, Ornstein MC, Kumar R, Hwang C, Shao Y, Park SH, Barata[...]

Inhibition of Acetyl-CoA-carboxylase induces endoplasmic reticulum stress and augments the efficacy of anti-cancer therapies

Shan NL, Balinda H, Dai J, Wang Y, Lin HK, Marczyk M, Espinoza Campos G, Umlauf S, McDermott MSJ, Colorado I, Lang SM, Surovtseva YV,[...]

Early-Onset Gastric Cancer as a High-Risk Disease Entity in the United States: Clinicopathologic Features, Regional Variation, and Outcomes

Castillo DR, Shah P, Tai D, Guo M, Hazeltine M, Guzman S, Park D, Mannan R, Xing Y, Brar G, Raoof M, Eng C, Wu[...]